Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGCT vs AEXA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CGCT Captures Overall Composite Edge (65.0 BUY vs 55.7 HOLD), While AEXA Leads 3–1 on Growth & Valuation Pillars

CGCT Overall Winner 6-Pillar Tally: CGCT 1 – 3 AEXA (2 Tie) Matrix Metrics: CGCT 3 – 2 AEXA

As of Nov 16, 2026, CGCT (CGCT) captures the overall head-to-head institutional edge over American Exceptionalism Acquisition Corp. A (AEXA) on higher Unified Composite conviction (65.0/100 BUY vs. 55.7/100 HOLD) after splitting the core matrix 3–2 (led by Valuation Multiples), while AEXA wins 3–1 across the 6-pillar growth and valuation breakdown. CGCT trades at $11.90 (N/M Forward P/E, 0.0% operating margin) versus AEXA at $10.72 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: CGCT earns the overall head-to-head edge with a stronger Unified Composite Score (65.0/100 BUY vs. AEXA 55.7/100 HOLD) and 0.17β · 85% Vol risk profile, whereas AEXA leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CGCT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.7); meanwhile AEXA is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGCT vs AEXA
CGCT US Equity Head-to-Head Winner
CGCT
Institutional Equity
$11.90
-2.14% 1D
Market Cap $509.6M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.17β · 85% Vol
Unified Composite Score
65.0 / 100 BUY
Tech 75.0 Fund 62.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 58
RSI-14: 57.7 · SMA20: $11.19 · SMA50: $10.66
AEXA NYSE
American Exceptionalism Acquisition Corp. A
Blank Checks
$10.72
-0.65% 1D
Market Cap $531.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.28β · 11% Vol
Unified Composite Score
55.7 / 100 HOLD
Tech 75.0 Fund 63.0 Flow 57.0 Mom 54.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.9%) with fading momentum, RSI 45
RSI-14: 45.2 · SMA20: $10.74 · SMA50: $10.94

6-Pillar Scorecard Institutional Category Breakdown (CGCT 1 – 3 AEXA)

Columns: Metric · CGCT · AEXA
1. Valuation Multiples CGCT
Forward P/E N/M N/M
Trailing P/E 41.0x N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale AEXA
Revenue Growth (YoY) +0.0% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A N/A
Market Cap $509.6M $531.7M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin 0.0% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) 0.0% 0.0%
4. Balance Sheet & Cash Flow AEXA
Cash Generation (TTM) N/A -$728,431
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AEXA
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 35.7% (4th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Shell Companies Operator Shell Companies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGCT (3) vs AEXA (2)
Institutional Metric CGCT AEXA Criterion Row Edge
Market Capitalization
Scale
$509.6M $531.7M Larger Scale AEXA
Trailing P/E Ratio
Valuation
41.0x N/M Lower Multiple CGCT
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +0.0% Higher Growth Tie
Operating Margin (TTM)
Profitability
0.0% 0.0% Higher Margin Tie
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
0.0% 0.0% Higher ROE Tie
52-Week Range Position
Momentum
44% ($9–$15) 15% ($10–$12) Stronger Trend CGCT
Beta / 30D Volatility
Risk Regime
0.17β · 85% Vol 0.28β · 11% Vol Lower Realized Risk AEXA
Unified Institutional Score
Composite Signal
65.0 / 100 (BUY) 55.7 / 100 (HOLD) Higher Composite CGCT
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) -$728,431 (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CGCT +15.1 pp
CGCT: +14.31% · AEXA: -0.79%
3M Horizon CGCT +15.24 pp
CGCT: +15.87% · AEXA: +0.63%
6M Horizon CGCT +16.34 pp
CGCT: +17.24% · AEXA: +0.9%
1Y Horizon CGCT +16.34 pp
CGCT: +17.24% · AEXA: +0.9%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGCT vs AEXA. Trailing 12-month operating profitability (CGCT 0.0% vs AEXA 0.0%) and valuation multiples (CGCT N/M vs AEXA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CGCT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
AEXA ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGCT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CGCT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AEXA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 35.7%
IV Percentile 4th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact AEXA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGCT Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $509.6M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AEXA Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $531.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CGCT vs AEXA Key Questions & Quantitative Answers

As of Nov 16, 2026, CGCT (CGCT) captures the overall head-to-head institutional edge over American Exceptionalism Acquisition Corp. A (AEXA) on higher Unified Composite conviction (65.0/100 BUY vs. 55.7/100 HOLD) after splitting the core matrix 3–2 (led by Valuation Multiples), while AEXA wins 3–1 across the 6-pillar growth and valuation breakdown. CGCT trades at $11.90 (N/M Forward P/E, 0.0% operating margin) versus AEXA at $10.72 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: CGCT earns the overall head-to-head edge with a stronger Unified Composite Score (65.0/100 BUY vs. AEXA 55.7/100 HOLD) and 0.17β · 85% Vol risk profile, whereas AEXA leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CGCT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.7); meanwhile AEXA is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AEXA leads the Growth & Scale pillar: CGCT posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with AEXA at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, CGCT generates N/A in USD-normalized revenue versus N/A for AEXA. In operating R&D and SG&A reinvestment, CGCT deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AEXA.

CGCT screens cheaper on headline valuation multiples. CGCT trades at N/M Forward P/E, 41.0x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AEXA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGCT (0.0% ROE) versus AEXA (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CGCT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.17β · 85% Vol realized risk). By comparison, AEXA carries 35.7% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.28β · 11% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.